Get started
Author

Lifei Shen

Observed names: L. Shen, Li-fei Shen, LiFei Shen, Shen, Lifei
Observed institutions: Shanghai Jiao Tong University, Fudan University, Ruijin Hospital, Fudan University Shanghai Cancer Center, Peking University Cancer Hospital, Chongqing Medical University
ORCID: 0000-0002-5470-261X
Observed ORCID: 0000-0002-5470-261X
OpenAlex ID: A5015394635
Ovarian thecoma-fibroma groups: clinical and sonographic features with pathological comparison
2016 · Hui Chen, Yan Liu, et al. · Journal of Ovarian Research · 56
PDF
Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer
2021 · Weiwei Feng, Nan Jia, et al. · Journal of Translational Medicine · 54
Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer
2023 · Jing Li, Ya Li, et al. · BMC Cancer · 34
PDF
BI 2536 induces gasdermin E-dependent pyroptosis in ovarian cancer
2022 · Jianting Huo, Yuhong Shen, et al. · Frontiers in Oncology · 34
RcsAB and Fur Coregulate the Iron-Acquisition System via entC in Klebsiella pneumoniae NTUH-K2044 in Response to Iron Availability
2020 · Lingyue Yuan, Xuan Li, et al. · Frontiers in Cellular and Infection Microbiology · 27
PDF
Efficacy and safety of larotrectinib as first-line treatment for patients with TRK fusion cancer
2025 · D.S. Hong, R.-H. Xu, et al. · ESMO Open · 19
Combination of FOXD1 and Plk2: A novel biomarker for predicting unfavourable prognosis of colorectal cancer
2022 · Yaping Zong, Yiming Miao, et al. · Journal of Cellular and Molecular Medicine · 18
PDF
Identification and Functional Validation of Differentially Expressed microRNAs in Ascites-Derived Ovarian Cancer Cells Compared with Primary Tumour Tissue
2021 · Yahui Jiang, Yiwen Shi, et al. · Cancer Management and Research · 12
PDF
Comparison of outcomes and side effects for neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation vs. chemoradiation alone in stage IIB–IVA cervical cancer: study protocol for a randomized controlled trial
2022 · Jing Li, Hua Liu, et al. · Trials · 11
PDF
The impact of Paclitaxel-based hyperthermic intraperitoneal chemotherapy in advanced high-grade serous ovarian cancer patients - interim analysis of safety and immediate efficacy of a randomized control trial (C-HOC trial)
2024 · Qun Wang, Hua Liu, et al. · Journal of Ovarian Research · 8
Regulation of ECP fimbriae‐related genes by the transcriptional regulator RcsAB in Klebsiella pneumoniae NTUH‐K2044
2022 · Lifei Shen, Jiaxue Zhang, et al. · Journal of Basic Microbiology · 8
Risk factor for lung infection in recipients after liver transplantation: A meta‐analysis
2020 · Jiaxue Zhang, Qiang He, et al. · Artificial Organs · 8
Transcriptional regulation of the yersiniabactin receptor fyuA gene by the ferric uptake regulator in Klebsiella pneumoniae NTUH‐K2044
2024 · Qian Yu, Hailin Li, et al. · Journal of Basic Microbiology · 7
TRIM4 modulates the ubiquitin-mediated degradation of hnRNPDL and weakens sensitivity to CDK4/6 inhibitor in ovarian cancer
2024 · Xiaoxia Che, Xin Guan, et al. · Frontiers of Medicine · 4
576P Safety and efficacy of IBI354 (anti-HER2 ADC) in patients (pts) with advanced gastrointestinal (GI) cancers: Results from a phase I study
2024 · J. Gong, C. Lemech, et al. · Annals of Oncology · 1
PDF
535P Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase (TRK) fusion cancer
2021 · M.S. Brose, L. Shen, et al. · Annals of Oncology · 1
146TiP MIRACLE3: Phase II study of ivonescimab plus radiotherapy and chemotherapy as first-line treatment in MSS colorectal cancer patients with unresectable liver/lung metastases
2025 · X. Li, Z. Shan, et al. · Annals of Oncology
PDF
A Phase III Randomized Clinical Trial: The Impact of Paclitaxel-Based Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (NLHIPEC) Followed by Sequential Intravenous Chemotherapy in Advanced High-Grade Serous Ovarian Cancer Patients - Interim Analysis of Safety and Immediate Efficacy from the C-HOC Trial
2023 · Qun Wang, Hua Liu, et al. · medRxiv
PDF
Mutational profiles of ovarian cancer in Chinese patients reveal potential therapeutic targets and prognostic markers
2022 · Tianjiao Lyu, Yahui Jiang, et al. · Research Square
PDF
Mutational profiles of ovarian cancer in Chinese patients revealed potential therapeutic targets and prognostic markers.
2021 · Weiwei Feng, Tianjiao Lyu, et al. · Journal of Clinical Oncology
Comparison of Outcomes and Side Effects for Neoadjuvant Chemotherapy with Weekly Cisplatin and Paclitaxel Followed by Chemoradiation versus Chemoradiation Alone in Stage IIB-IVA Cervical Cancer: study protocol for a randomized controlled trial
2021 · Jing Li, Rong Cai, et al. · Research Square
PDF
Additional file 1 of Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer
2021 · Feng, Weiwei, Jia, Nan, et al. · Figshare
Additional file 3 of Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer
2021 · Feng, Weiwei, Jia, Nan, et al. · Figshare
Additional file 2 of Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer
2021 · Feng, Weiwei, Jia, Nan, et al. · Figshare
Additional file 5 of Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer
2021 · Feng, Weiwei, Jia, Nan, et al. · Figshare
Works count: 30
Citation count: 302
H-index: 9
I10-index: 9
Year
Topic
Type